Form 8-K - Current report:
SEC Accession No. 0000320017-15-000079
Filing Date
2015-11-09
Accepted
2015-11-09 07:03:24
Documents
2
Period of Report
2015-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kprq32015.htm 8-K 23686
2 EXHIBIT 99.1 exhibit991prq32015.htm EX-99.1 87697
  Complete submission text file 0000320017-15-000079.txt   112830
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 151213938
SIC: 8090 Services-Misc Health & Allied Services, NEC